BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 1626949)

  • 1. [Biochemical modulation--the historical background].
    Tsukagoshi S
    Gan To Kagaku Ryoho; 1992 Jul; 19(7):941-5. PubMed ID: 1626949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Improving the anti-tumor activity of 5-fluorouracil by methotrexate].
    Konishi T; Noie T; Abe T; Agawa S; Furushima K; Ito K; Mafune K; Makuuchi M; Teruya M; Nouchi T
    Gan To Kagaku Ryoho; 1999 Mar; 26(4):431-9. PubMed ID: 10097739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Optimal administration in combination chemotherapy with 5-fluorouracil and cisplatin for gastric cancer].
    Maeda Y; Sasaki T
    Gan To Kagaku Ryoho; 1996 Nov; 23(13):1763-9. PubMed ID: 8937486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A phase II study of weekly methotrexate, cisplatin, and 24-hour infusion of high-dose 5-fluorouracil and leucovorin (MP-HDFL) in patients with metastatic and recurrent esophageal cancer-improving toxicity profile by infusional schedule and double biochemical modulation of 5-fluorouracil.
    Hsu CH; Cheng AL; Hsu C; Yang CH; Lu YS; Lin CC; Bu CF; Yeh KH
    Anticancer Res; 2002; 22(6B):3621-7. PubMed ID: 12552966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Combined chemotherapy with 5-FU+cis-platin or UFT+cisplatin].
    Hirata K
    Gan To Kagaku Ryoho; 1995 Jul; 22(8):1009-17. PubMed ID: 7611751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Biochemical modulation with sequential methotrexate (MTX)-5-fluorouracil (5-FU) treatment].
    Ota K; Murakami M
    Gan To Kagaku Ryoho; 1987 May; 14(5 Pt 2):1642-9. PubMed ID: 3496047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Combination chemotherapy for gastric cancer including LV/5-FU].
    Sasaki T; Maeda Y; Kandaba-shi K; Ono M
    Gan To Kagaku Ryoho; 2004 Nov; 31(12):1952-6. PubMed ID: 15570919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A combination immunochemotherapy of 5-fluorouracil, cisplatin, leucovorin, and OK-432 for advanced and recurrent gastric carcinoma.
    Yoshikawa T; Tsuburaya A; Kobayashi O; Sairenji M; Motohashi H; Noguchi Y
    Hepatogastroenterology; 2003; 50(54):2259-63. PubMed ID: 14696512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A case of nonresectable scirrhous type gastric cancer successfully treated by low-dose cisplatin (CDDP), 5-fluorouracil (5-FU) and pirarubicin (THP)].
    Gochi A; Murashima N; Gotoh K; Matsuno T; Matsuoka J; Tanaka N; Orita K
    Gan To Kagaku Ryoho; 2000 Jun; 27(6):905-8. PubMed ID: 10897219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjuvant treatment of high-risk, radically resected gastric cancer patients with 5-fluorouracil, leucovorin, cisplatin, and epidoxorubicin in a randomized controlled trial.
    Cascinu S; Labianca R; Barone C; Santoro A; Carnaghi C; Cassano A; Beretta GD; Catalano V; Bertetto O; Barni S; Frontini L; Aitini E; Rota S; Torri V; Floriani I; ; Pozzo C; Rimassa L; Mosconi S; Giordani P; Ardizzoia A; Foa P; Rabbi C; Chiara S; Gasparini G; Nardi M; Mansutti M; Arnoldi E; Piazza E; Cortesi E; Pucci F; Silva RR; Sobrero A; Ravaioli A
    J Natl Cancer Inst; 2007 Apr; 99(8):601-7. PubMed ID: 17440161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Sequential methotrexate and 5-fluorouracil].
    Sasaki T
    Gan To Kagaku Ryoho; 1996 Dec; 23(14):1907-10. PubMed ID: 8978795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 5-Fluorouracil, methotrexate, leucovorin, CDDP and epirubicin (FEPMTX): a wide-spectrum regimen of salvage chemotherapy for high-grade advanced gastric cancer.
    Kinoshita K; Yonemura Y; Sawa T; Miyata T; Sakuma H; Matsuki N; Tanaka S; Fushida S; Fujimura T; Mok YJ; Kim BS; Lee JI; Choi DW; Song YJ; Yang DH; Kwon SJ; Tanaka M; Miyazaki I
    Hepatogastroenterology; 2003; 50(53):1716-9. PubMed ID: 14571825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A case of gastric cancer completely responding to sequential methotrexate and 5-fluorouracil therapy].
    Ono M; Ishikawa H; Suzuki N; Miura T; Kaga S; Kano A
    Gan To Kagaku Ryoho; 1994 Sep; 21(12):2035-8. PubMed ID: 8085854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A case of long-term survival of 3-years 4 months after combination chemotherapy of MTX, 5-FU and low-dose CDDP (MFP) for type 4 gastric cancer with pleuritis, peritoneal dissemination and Krukenberg tumor].
    Nakayama N; Tanabe S; Koizumi W; Higuchi K; Sasaki T; Nakatani K; Shimoda T; Nishimura K; Kobayashi N; Mitomi H; Saigenji K
    Gan To Kagaku Ryoho; 2006 Nov; 33(11):1641-4. PubMed ID: 17108732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Sequential chemotherapy with methotrexate and 5-fluorouracil for advanced gastric cancer].
    Iwamoto S; Kimoto M; Mure T; Onuma E; Yamamoto Y; Iki K; Yoshida K; Tadaoka Y; Majima T; Kawasaki S; Kubozoe T; Tsunoda T
    Gan To Kagaku Ryoho; 1998 Mar; 25(4):541-6. PubMed ID: 9530360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [MTX/CDDP/5-FU double modulation intra-peritoneal chemotherapy for advanced and metastatic gastric cancer--comparison with intra-aortic route and intra-venous route].
    Maruyama M; Ebuchi M; Takashima K; Maruyama S; Hasegawa K; Ohbe M; Koide A; Shinoura Y; Katoh K
    Gan To Kagaku Ryoho; 2004 Oct; 31(11):1714-6. PubMed ID: 15553692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Arterial infusion chemotherapy combined with biochemical modulation in cancer patients].
    Suga T; Takahashi Y; Ogino T; Mai M
    Gan To Kagaku Ryoho; 1991 Aug; 18(11):1962-4. PubMed ID: 1908662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Dual biochemical modulation therapy using 5-FU, leucovorin and cisplatin on human rectal carcinoma xenografts in nude mouse].
    Shibusawa M; Takata M; Kamiyama G; Yokoyama N; Nakao K; Yoshizawa H; Choh H; Yasuda N; Tsunoda Y; Tsunoda A; Kusano M
    Gan To Kagaku Ryoho; 1996 Aug; 23(9):1149-52. PubMed ID: 8751802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Methotrexate and 5-fluorouracil with leucovorin therapy in advanced gastric cancer: the enhancement of 5-fluorouracil antitumor activity by leucovorin].
    Sugiura I; Ogasawara T; Kinoshita T; Ono Y; Onizuka T; Nagata K; Kamiya O; Ohara K; Hoshino A
    Gan To Kagaku Ryoho; 1987 Jun; 14(6 Pt 1):1938-40. PubMed ID: 3496053
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical effect and characteristics of low dose leucovorin and high dose 5-FU therapy in patients with recurrent gastric cancer--a new method of biochemical modulation].
    Kajiyama Y; Tsurumaru M; Ono Y; Udagawa H; Watanabe G; Suzuki M; Matsuda M; Akiyama H
    Gan To Kagaku Ryoho; 1993 Sep; 20(12):1797-801. PubMed ID: 8379672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.